首页> 外文期刊>Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists >OSTEOPROTEGERIN IS A BETTER SERUM BIOMARKER OF CORONARY ARTERY CALCIFICATION THAN OSTEOCALCIN IN TYPE 2 DIABETES
【24h】

OSTEOPROTEGERIN IS A BETTER SERUM BIOMARKER OF CORONARY ARTERY CALCIFICATION THAN OSTEOCALCIN IN TYPE 2 DIABETES

机译:与2型糖尿病的骨钙素相比,骨钙蛋白是冠状动脉钙化的更好的血清生物标志物

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Objective: Coronary artery calcification (CAC) is a prominent feature of atherosclerosis and is associated with cardiovascular events. In vitro studies have suggested that osteoprotegerin (OPG) and osteocalcin (OC) exert anticalcification potential in the vessel wall. The objective of this study was to investigate the association of CAC and serum bone biomarkers in persons with type 2 diabetes.
机译:目的:冠状动脉钙化(CAC)是动脉粥样硬化的突出特征,并与心血管事件有关。体外研究表明,骨保护素(OPG)和骨钙蛋白(OC)在血管壁发挥抗钙化作用。这项研究的目的是调查2型糖尿病患者中CAC与血清骨生物标志物的关系。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号